Playback speed
10 seconds
ACC 2022: Long-term Safety and Tolerability of Acoramidis in Symptomatic Transthyretin Amyloid Cardiomyopathy
By
ACC 2022 Conference Coverage
FEATURING
Ahmad Masri
By
ACC 2022 Conference Coverage
FEATURING
Ahmad Masri
90 views
April 8, 2022
Comments 0
Login to view comments.
Click here to Login